Navigation Links
The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance
Date:12/1/2008

ccounts payable $621,115 $806,134 Accrued expenses 2,385,540 1,532,170 Preferred dividends payable 25,068 53,025 Total current liabilities 3,031,723 2,391,329 Obligations under capital leases 49,597 23,176 Deferred gain on sale of facilities 836,733 1,074,339 Deferred grant income 203,483 257,245 Total liabilities 4,121,536 3,746,089 Total stockholders' equity 9,709,202 7,447,459 Total liabilities and stockholders' equity $13,830,738 $11,193,548 The Female Health Company Unaudited Condensed Consolidated Income Statements For the 3 Months Ended For the 12 Months Ended September 30, September 30, 2008 2007 2008 2007 Net revenues $7,839,973 $5,174,227 $25,634,126 $19,319,889 Cost of products sold 4,326,660 3,143,306 14,904,325 12,163,574 Gross profit 3,513,313 2,030,921 10,729,801 7,156,315 Advertising and promotion 62,455 48,854 223,800 179,874 Selling, general and administrative 2,138,314 1,527,722 7,038,060 5,864,436 Research and development 81,975 51,939 284,216 208,608 Total operating expenses 2,282,744 1,628,515 7,546,076 6,252,918 Operating income 1,230,569 402,406 3,183,725 903,397 Interest income, net of expense (22,816) (784) (53,445) (36,004) Foreign currency transactions (gain) loss (893,11
'/>"/>
SOURCE The Female Health Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. The Female Health Company to Present at Rodman & Renshaw 10th Annual Global Investment Conference
2. The Female Health Company Reports Record Profit for Both Fourth Quarter and Fiscal Year 2007
3. Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD)
4. Regado Biosciences to Present at the Piper Jaffray Health Care Conference on Tuesday, December 2, 2008
5. Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist
6. Beckman Coulter to Present at Upcoming Healthcare Conferences
7. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
8. MannKind to Present at the Piper Jaffray 20th Annual Health Care Conference
9. Sangamo BioSciences to Webcast Annual Investor and Analyst Briefing and Presentation at Piper Jaffray Health Care Conference
10. Celator(R) Pharmaceuticals to Present at Piper Jaffray Health Care Conference and Mid-Atlantic Capital Conference
11. BioMarin to Present at the Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014 Product and ... very low abundance and are often “lost in ... time-consuming. , Join presenters Dr. Rowel Tobias, Senior ... John Anders, Head of Quality at Nanotherapeutics, Inc., ... that can speed detection and quantitation while achieving ...
(Date:7/10/2014)... Understanding the need for better quality and higher ... that currently exists in this area, ChanTest has recently ... validated ion channel and GPCR cell lines. ChanTest’s ... channels control many critical physiological functions throughout the body. ... to treat a variety of human diseases. , ...
(Date:7/10/2014)... CA (PRWEB) July 10, 2014 Unraveling ... closer together. The Archer Family purchased a ... within DNA, but ended up with a lifetime of ... contained within the family members’ DNA genuinely brought the ... decided to search deeper into genetic history and prior ...
(Date:7/10/2014)... 10, 2014 OMICS Group’s 5th International ... 18-20 August, 2014 at Double Tree by Hilton Beijing, ... developments in Analytical & Bioanalytical research methods only to ... on this occasion, Dr. Srinubabu Gedela, MD of OMICS ... is a remarkable one in bringing a unique and ...
Breaking Biology Technology:Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 4Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 5A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4
... MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, ... and bioimplants processed from human amniotic membrane, announced ... Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders ... Petit, Chairman and CEO, William C. Taylor, President ...
... and TORONTO, Dec. 1, 2011 Generex Biotechnology Corporation ... on the status of the clinical and regulatory ... insulin spray product. Work has been ... analyses), and revising all of the extant Generex ...
... Calif., Dec. 1, 2011  VIVUS, Inc. (NASDAQ: VVUS ... present an overview of the company at the 2011 Deutsche ... place at the Four Seasons Hotel, Boston, MA on Tuesday, ... and 30-day archive of the presentation will be available at ...
Cached Biology Technology:Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program 2Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program 3Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program 4VIVUS to Present at the Deutsche Bank BioFEST Conference 2VIVUS to Present at the Deutsche Bank BioFEST Conference 3
(Date:7/11/2014)... German . ... refraction of X-rays through a specimen instead of attenuation ... are often of much higher quality than those based ... Franz Pfeiffer are particularly interested in developing new approaches ... phase-contrast imaging. One main goal is to make this ...
(Date:7/11/2014)... National Institute of Standards and Technology (NIST) need ... effectively, they often prove that necessity is truly ... recently for M. Lorna De Leoz and Stephen ... of glycomics. Glycomics is the study of the ... attached to proteins and lipids and influence cellular ...
(Date:7/11/2014)... China Researchers from Salk Institute for Biological Studies, ... evaluated the safety and reliability of the existing ... new method, TALEN-HDAdV, which could significantly increased gene-correction ... This study published online in Cell Stell ... stem cell-based gene therapy. , The combination of ...
Breaking Biology News(10 mins):New simple setup for X-ray phase contrast 2A new genome editing method brings the possibility of gene therapies closer to reality 2
... target for a drug seems very promising on paper; ... of telomerase inhibitors,to treat cancer; they are supposed to ... cells. Yet, something in the cell,seems to block their ... do then? Scrap the project? Look for something,else? Hell ...
... in humans in forests between Gabon and the Republic ... animal carcasses, according to a study by the Wildlife ... the February edition of the journal Emerging Infectious Diseases, ... Ebola between 2001 and 2003 produced positive results, and ...
... by human activity and the extinction of species around ... warns a Canadian zoologist. This ecological damage also endangers ... , Dr. Daniel (Dan) Brooks, a parasitologist at the ... is linked to the emergence of new human and ...
Cached Biology News:Combination therapy boosts effectiveness of telomere-directed cancer cell death 2Study Links Ebola Outbreaks To Animal Carcasses 2Ecological destruction fuels emerging diseases 2
Mouse monoclonal [6911] to E. coli K99 pilus ( Abpromise for all tested applications)....
...
... genetically encoded fluorescent sensor capable for high ... one of the main ROS generated by ... fluorescent protein inserted into the regulatory domain ... demonstrates submicromolar affinity to H2O2 and at ...
Alexa Fluor 647 anti-mouse Qa-2...
Biology Products: